Small molecule inhibitors of the human MDM2-p53 interaction as anticancer agents

被引：1
|
作者：
Wang, S. [1 ]
Shangary, S. [1 ]
Qin, Q. [1 ]
McEachern, D. [1 ]
Ding, K. [1 ]
Nikolovska-Coleska, Z. [1 ]
Lu, Y. [1 ]
Malek, S. [1 ]
Guo, M. [2 ]
Yang, D. [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Ascenta Therapeut, Res, Malvern, PA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72188-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction
    Bista, Michal
    Wolf, Siglinde
    Khoury, Kareem
    Kowalska, Kaja
    Huang, Yijun
    Wrona, Ewa
    Arciniega, Marcelino
    Popowicz, Grzegorz M.
    Holak, Tad A.
    Domling, Alexander
    STRUCTURE, 2013, 21 (12) : 2143 - 2151
  • [22] Isoquinolin-1-one inhibitors of the MDM2-p53 interaction
    Rothweiler, Ulli
    Czarna, Anna
    Krajewski, Marcin
    Ciombor, Jolanta
    Kalinski, Cedric
    Khazak, Vladimir
    Ross, Guenther
    Skobeleva, Natalia
    Weber, Lutz
    Holak, Tad A.
    CHEMMEDCHEM, 2008, 3 (07) : 1118 - 1128
  • [23] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [24] Structural details on mdm2-p53 interaction
    Chi, SW
    Lee, SH
    Kim, DH
    Ahn, MJ
    Kim, JS
    Woo, JY
    Torizawa, T
    Kainosho, M
    Han, KH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (46) : 38795 - 38802
  • [25] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
    Shangary, Sanjeev
    Wang, Shaomeng
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 223 - 241
  • [26] Structure-based design of highly potent, specific, orally active small-molecule inhibitors of the MDM2-p53 interaction as a new class of anticancer therapy
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [27] Discovery of SCY45, a Natural Small-Molecule MDM2-p53 Interaction Inhibitor
    Gong, Haifeng
    An, Juan
    Dong, Qiuxia
    Li, Jinxian
    Yang, Wei
    Sun, Wei
    Su, Zhanhai
    Zhang, Shoude
    CHEMISTRY & BIODIVERSITY, 2019, 16 (06)
  • [28] Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
    Bhatia, Neha
    Khator, Rakesh
    Kulkarni, Swanand
    Singh, Yogesh
    Kumar, Pradeep
    Thareja, Suresh
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (32) : 3668 - 3701
  • [29] Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
    Kemp, SJ
    Hardcastle, IR
    Ahmed, SU
    Atatreh, NA
    Barrett, P
    Endicott, JA
    Golding, BT
    Griffin, RJ
    Gruber, J
    Hutton, C
    Lunec, J
    Noble, MEM
    Reid, RJ
    Riedinger, C
    Smyth, LA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2735 - U2736
  • [30] Novel inhibitors of the MDM2-p53 interaction featuring carboxylic acid isosteres
    Gonzalez, Ana Z.
    Li, Zhihong
    Beck, Hilary P.
    Canon, Jude
    Chen, Ada
    Chow, David
    Duquette, Jason
    Eksterowicz, John
    Fox, Brian M.
    Fu, Jiasheng
    Huang, Xin
    Houze, Jonathan
    Jin, Lixia
    Li, Yihong
    Ling, Yun
    Lo, Mei-Chu
    Long, Alexander M.
    Mcgee, Lawrence R.
    McIntosh, Joel
    Oliner, Jonathan D.
    Osgood, Tao
    Rew, Yosup
    Saiki, Anne Y.
    Shaffer, Paul
    Wortman, Sarah
    Yakowec, Peter
    Yan, Xuelei
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Olson, Steven H.
    Sun, Daqing
    Medina, Julio C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
12345